Primevera Therapeutics

Primavera Therapeutics is a biotechnology company focused on developing the first comprehensive platform of therapies to treat and eliminate Human Papillomavirus (HPV) infections and associated cancers. Launched by Apple Tree Partners (ATP), the company leverages novel insights into viral persistence to develop small molecule antivirals that target the root cause of HPV-driven diseases. Their pipeline aims to address a broad spectrum of conditions, from asymptomatic infections to late-stage malignancies like cervical and oropharyngeal cancers. By focusing on the viral drivers rather than just the symptoms, Primavera seeks to provide curative options for the millions of people affected by HPV worldwide.